Deutsche Bank Initiates Coverage on AtaiBeckley with 'Buy' Rating and $12 Price Target
ByAinvest
Friday, Mar 27, 2026 11:28 am ET1min read
ATAI--
Deutsche Bank initiates coverage on AtaiBeckley with a "Buy" rating and sets a price target of $12, implying 320% potential upside. Analysts highlight the company's lead programs for treatment-resistant depression and seasonal affective disorder, and note that upcoming Phase 2 data could provide near-term catalysts for the stock. The firm believes AtaiBeckley will become a leader in psychedelic medicine for mental health conditions.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet